首页> 外文期刊>Diabetes >Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer-Restricted CD4~+ T Cells Infiltrate Islets in Type 1 Diabetes
【24h】

Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer-Restricted CD4~+ T Cells Infiltrate Islets in Type 1 Diabetes

机译:胰岛素原特异性,HLA-DQ8和HLA-DQ8-二聚体限制型CD4〜+ T细胞浸润1型糖尿病的胰岛

获取原文
获取原文并翻译 | 示例
       

摘要

Type 1 diabetes (T1D) develops when insulin-secreting β-cells, found in the pancreatic islets of Langerhans, are destroyed by infiltrating T cells. How human T cells recognize β-cell-derived antigens remains unclear. Genetic studies have shown that HLA and insulin alleles are the most strongly associated with risk of T1D. These longstanding observations implicate CD4~+ T-cell responses against (pro)insulin in the pathogenesis of T1D. To dissect the autoimmune T-cell response against human β-cells, we isolated and characterized 53 CD4~+ T-cell clones from within the residual pancreatic islets of a deceased organ donor who had T1D. These 53 clones expressed 47 unique clonotypes, 8 of which encoded proinsulin-specific T-cell receptors. On an individual clone basis, 14 of 53 CD4~+ T-cell clones (26%) recognized 6 distinct but overlapping epitopes in the C-peptide of proinsulin. These clones recognized C-peptide epitopes presented by HLA-DQ8 and, notably, HLA-DQ8 transdimers that form in HLA-DQ2/-DQ8 heterozygous individuals. Responses to these epitopes were detected in the peripheral blood mononuclear cells of some people with recent-onset T1D but not in HLA-matched control subjects. Hence, proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4~+ T cells are strongly implicated in the autoimmune pathogenesis of human T1D.
机译:当在朗格汉斯的胰岛中发现的分泌胰岛素的β细胞被T细胞浸润破坏时,就会发展为1型糖尿病(T1D)。人类T细胞如何识别β细胞源性抗原尚不清楚。遗传研究表明,HLA和胰岛素等位基因与T1D风险最密切相关。这些长期的观察表明,在T1D的发病机理中,CD4〜+ T细胞对(原)胰岛素的反应。为了剖析针对人β细胞的自身免疫性T细胞应答,我们从患有T1D的已故器官供体的残余胰岛中分离并鉴定了53个CD4〜+ T细胞克隆。这53个克隆表达了47种独特的克隆型,其中8种编码胰岛素原特异性T细胞受体。在单个克隆的基础上,53个CD4〜+ T细胞克隆中的14个(占26%)识别胰岛素原C肽中的6个不同但重叠的表位。这些克隆识别HLA-DQ8呈递的C肽表位,尤其是在HLA-DQ2 / -DQ8杂合体个体中形成的HLA-DQ8转二聚体。在一些最近发作的T1D患者的外周血单核细胞中检测到了对这些表位的反应,但在HLA匹配的对照受试者中未检测到。因此,胰岛素原特异性,HLA-DQ8和HLA-DQ8-二聚体限制型CD4 + T细胞与人T1D的自身免疫性发病机制密切相关。

著录项

  • 来源
    《Diabetes》 |2015年第1期|172-182|共11页
  • 作者单位

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia;

    Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;

    National Pancreas Transplant Unit, University of Sydney at Westmead Hospital, Sydney, New South Wales, Australia;

    Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia;

    University of Melbourne, Northwest Academic Centre, Sunshine Hospital, St. Albans, Victoria, Australia;

    Department of Paediatrics, Monash University, Clayton, Victoria, Australia;

    Department of Paediatrics, Monash University, Clayton, Victoria, Australia;

    Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia;

    Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;

    Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia,Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:14

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号